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Background:  Although drug-eluting stents (DES) have shown favorable outcomes in diabetic patients, there are few data assessing the effect of 
blood glucose control on clinical outcomes of DES.
Methods:  We performed coronary stent implantation using DES in 221 non-insulin-dependent diabetes mellitus (NIDDM) patients with 292 
lesions. Patients were divided into two groups according to glycosylated hemoglobin level at implantation of DES. Good control group (G group; 
HbA1c<6.5) consisted of 103 patients with 134 lesions and poor control group (P group; HbA1c≥6.5) consisted of 118 patients with 158 lesions. 
In-stent restenosis lesions and coronary bypass graft lesions were excluded in this study. We retrospectively evaluated in-stent late lumen loss, binary 
restenosis rate at the 9-month angiographic follow-up, and major adverse cardiac events (MACE) at the 1-year clinical follow-up.
Results:  There were more hypertensive patients in P group (74% vs. 61%, p<0.05). There were no significant differences in baseline patient 
characteristics except drug administration for DM. There were no significant differences in vessel diameter (2.52 ± 0.40 mm in G group vs. 2.60 
± 0.44 mm in P group), lesion length (16.2 ± 7.2 mm in G group vs. 16.6 ± 8.5 mm in P group) and procedural characteristics. There was no 
significant difference in late lumen loss between two groups (0.29 ± 0.44mm in G group vs. 0.32 ± 0.51mm in P group). Binary restenosis rate was 
similar in both groups (5.1% in G group vs. 7.8% in P group). Major adverse cardiac event rate at the 1-year follow-up was similar in both groups 
(11.1% in G group vs. 12.4% in P group, p=ns).
Conclusions:  Blood glucose control did not have an effect on the long-term clinical outcomes after drug-eluting stent implantation in our NIDDM 
patients group.
